Trials / Completed
CompletedNCT00219804
Efficacy and Safety of Tetrabenazine in Chorea
A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Prestwick Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study was to establish the absolute reduction of chorea in participants with Huntington's disease(HD) treated with tetrabenazine or placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tetrabenazine or placebo |
Timeline
- First posted
- 2005-09-22
- Last updated
- 2005-09-22
Source: ClinicalTrials.gov record NCT00219804. Inclusion in this directory is not an endorsement.